참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Allyl bromide | HCID 7841 | — |
| 반응물 | Diisopropylamine | HCID 7912 | — |
| 반응물 | Tetrahydrofuran | HCID 8028 | — |
| 반응물 | Ethyl 3-oxocyclohexanecarboxylate | HCID 118096 | — |
| 반응물 | Butyllithium | HCID 178418339 | — |
| 용매 | Hexane | HCID 8058 | — |
| 생성물 | 7-Allyl-1,4-dioxa-spiro[4.5]decane-7-carboxylic acid ethyl ester | HCID 58237202 | 81% |
반응 단계
Then, to a round bottom flask was added N,N-diisopropylamine (3.97 mL, 28.4 mmol) and THF (22.1 mL). The mixture was cooled at −20° C. 1.6 M of n-butyllithium in hexane (15.8 mL) was added. The crude mixture was stirred at 0° C. for 30 min and then cooled down at −20° C., and 1,4-dioxa-spiro[4.5]dicane-7-carboxylic acid ethyl ester (4.50 g, 21.0 mmol) from step 1 was added dropwise. The mixture was stirred at 0° C. for 30 min, and then cooled at −20° C., and allyl bromide (2.00 mL, 23.1 mmol) was added. The mixture was warmed up to rt slowly and stirred at rt for 30 min. The reaction mixture was quenched with ice, diluted with ethyl acetate (60 mL), and washed sequentially with 1N aqueous HCl (5 mL), water and brine. The organic layer was dried over Na2SO4 and concentrated under reduced pressure to afford 4.30 g (81%) of the title compound, 7-allyl-1,4-dioxa-spiro[4.5]decane-7-carboxylic acid ethyl ester, as a yellow oil. It was used in the next step without further purification. 1H NMR (400 MHz, CDCl3): δ5.64-5.74 (m, 1H), 4.97-5.05 (m, 2H), 4.05-4.17 (m, 2H), 3.82-3.99 (m, 4H), 2.34-2.41 (m, 1H), 2.27 (dt, J=13.6, 2.1 Hz, 1H), 2.08-2.16 (m, 2H), 1.76-1.88 (m, 1H), 1.60-1.72 (m, 2H), 1.46-1.54 (m, 1H), 1.42 (d, J=13.6 Hz, 1H), 1.25 (t, J=7.1 Hz, 3H), 1.08-1.16 (m, 1H).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US09359297B2 |
|---|
| 출처 데이터셋 | uspto-grants-2016_06 |
|---|
| ORD ID | ord-874eba3c01314da1bfad97b7314380c7 |
|---|
| 출처 메모 | uspto-grants-2016_06 |
|---|